Business description: Artivion, Inc.

Artivion, Inc. is a medical device company focused on developing solutions that address cardiac and vascular surgeons in treating patients with aortic diseases. The Company operates through two segments, which include Medical Devices and Preservation Services. The Medical Devices segment includes sales of aortic stent grafts, surgical sealants, On-X products, and other products. The Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. It has four product families: aortic stent grafts, On-X mechanical heart valves and related surgical products, surgical sealants, and implantable cardiac and vascular human tissues. Its aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Its surgical sealants include BioGlue Surgical Adhesive products. It is engaged in the endovascular repair of aortic arch disease and the developer of the NEXUS Aortic Arch System.

Number of employees: 1,800

Sales by Activity: Artivion, Inc.

Fiscal Period: December 2021 (USD) 2022 (USD) 2023 (USD) 2024 (USD) 2025 (USD)

Medical Devices

222M 230M 261M 290M 346M

Preservation Services

77.24M 83.44M 92.82M 98.31M 95.5M

Geographical breakdown of sales: Artivion, Inc.

Fiscal Period: December 2021 (USD) 2022 (USD) 2023 (USD) 2024 (USD) 2025 (USD)

North America

- - - 198M 222M

Europe The Middle East and Africa

- - - 132M 151M

Asia Pacific

- - - 37.2M 44.25M

Latin America

- - - 21.88M 23.97M

Other International

118M - - - -

Germany

29.88M - - - -

U.S.

151M 161M 179M - -

International

- 153M 175M - -

Executive Committee: Artivion, Inc.

Manager TitleAgeSince
Chief Executive Officer 59 2014-09-01
Director of Finance/CFO 53 2023-12-03
Chief Tech/Sci/R&D Officer - -
Chief Tech/Sci/R&D Officer 56 2023-05-31
Compliance Officer 68 2015-09-30

Composition of the Board of Directors: Artivion, Inc.

Director TitleAgeSince
Director/Board Member 71 2003-11-30
Director/Board Member 66 2003-11-30
Director/Board Member 61 2012-04-30
Chairman 59 2015-04-09
Director/Board Member 69 2016-10-24
Director/Board Member 63 2017-09-28
Director/Board Member 72 2018-06-18
Director/Board Member 74 2021-09-30
Director/Board Member 60 2022-09-30

Shareholders: Artivion, Inc.

NameStocks%Valuation
BlackRock Advisors LLC
13.15 %
6,381,933 13.15 % 171 M $
Vanguard Fiduciary Trust Co.
6.582 %
3,195,211 6.582 % 86 M $
Nomura Investment Management Business Trust
6.561 %
3,184,974 6.561 % 85 M $
Morgan Stanley Capital Services LLC
5.269 %
2,557,961 5.269 % 69 M $
Juniper Investment Co. LLC
4.161 %
2,019,885 4.161 % 54 M $

Company details: Artivion, Inc.

Artivion, Inc.

1655 Roberts Boulevard NW

30144-3632, Kennesaw

+770 419 3355

http://www.artivion.com
address Artivion, Inc.(AORT)

Group companies: Artivion, Inc.

NameCategory and Sector
Medical Specialties

Other Medical Equipment, Supplies & Distribution

Change 5-day change 1-year change 3-year change Capi.($)
+0.37%+2.69%-38.33%+55.60% 1.32B
-1.30%-6.20%-17.89%+5.91% 188B
+1.53%+0.99%-0.83%+12.07% 118B
+2.28%+0.89%+13.50%+89.17% 63.16B
-1.89%-2.18%+26.20%+48.54% 52.01B
-0.53%-1.40%-3.04%-32.80% 50.97B
-1.01%+1.10%+19.64%-11.54% 34.02B
+0.23%-1.49% - - 30.8B
-0.72%-2.82%+37.13%-16.93% 23.83B
-2.97%-4.00%-7.37%+13.67% 23.45B
Average -0.40%-1.22%+3.22%+18.19% 58.59B
Weighted average by Cap. -0.27%-2.59%-0.14%+15.53%
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
27.09USD
Average target price
42.15USD
Spread / Average Target
+55.59%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. AORT Stock
  4. Company Artivion, Inc.